Search Results
Results for: MTS SECURITIES (Save this search)
Number of Results: 14
Alliqua BioMedical, Adynxx Merge to Create Pharmaceutical Company with Focus on Pain/Inflammation
16 October 2018 - Pennsylvania, US-based pharmaceutical company Alliqua BioMedical, Inc. (NASDAQ: ALQA) has entered into a merger agreement with San Francisco, US-based pharmaceuti...

ALLIQUA BIOMEDICAL, ADVNXX MERGE TO CREATE PHARMACEUTICAL COMPANY WITH FOCUS ON PAIN/INFLAMMATION
Pennsylvania, US-based pharmaceutical company Alliqua BioMedical, Inc. (NASDAQ: ALQA) has entered into a merger agreement with San Francisco, US-based pharmaceutical company Adynxx...

Ligand Closes GBP 32.8m Acquisition of UK Structure-Based Drug Discovery Specialist Vernalis
11 October 2018 - US-based drugmaker Ligand Pharmaceuticals Inc. (NASDAQ: LGND) has closed the acquisition of the entire issued and to be issued shares of UK-based Vernalis pl...

LIGAND CLOSES GBP 32.8M ACQUISITION OF UK STRUCTURE-BASED DRUG DISCOVERY SPECIALIST VERNALIS
US-based drugmaker Ligand Pharmaceuticals Inc. (NASDAQ: LGND) has closed the acquisition of the entire issued and to be issued shares of UK-based Vernalis plc (LSE: VER) throu...

Ligand Makes Offer to Acquire UK Structure-Based Drug Discovery Specialist Vernalis for GBP 32.8m
10 August 2018 - US-based drugmaker Ligand Pharmaceuticals Inc. (NASDAQ: LGND) has declared its firm intention to acquire the entire issued and to be issued shares of UK-based...

pSivida Acquires Icon Bioscience to Accelerate Transformation to Biopharmaceuticals
4 April 2018 - Massachusetts, US-based biopharmaceutical company pSivida Corp. (NASDAQ: PSDV) (ASX: PVA) has acquired specialty biopharmaceutical company Icon Bioscience Inc. whose...

PSIVIDA ACQUIRES ICON BIOSCIENCE TO ACCELERATE TRANSFORMATION TO BIOPHARMACEUTICALS
Massachusetts, US-based biopharmaceutical company pSivida Corp. (NASDAQ: PSDV) (ASX: PVA) has acquired specialty biopharmaceutical company Icon Bioscience Inc. whose lead product D...

Diffusion Pharmaceuticals, RestorGenex Close Merger
13 January 2016 - US-based biopharmaceutical company RestorGenex Corp. (OTCQX: RESX) and US-based biotechnology company Diffusion Pharmaceuticals LLC have completed a merger under ...

DIFFUSION PHARMACEUTICALS, RESTORGENEX CLOSE MERGER
US-based biopharmaceutical company RestorGenex Corp. (OTCQX: RESX) and US-based biotechnology company Diffusion Pharmaceuticals LLC have completed a merger under which a newly form...

You can compare news articles by clicking on the tick buttons
1   2   >